Dianthus Therapeutics | MGTA - Trade Debtors



Dianthus Therapeutics reported $39K in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Adcock Ingram Holdings ZAR 2.31B 53.49M Dec/2024
Alaunos Therapeutics USD 5K 5K Dec/2024
Avita Medical AUD 11.96M 1.95M Dec/2024
Celltrion KRW 1.28T 205.45B Mar/2025
Cspc Pharmaceutical CNY 9.62B 2.01B Dec/2024
Dianthus Therapeutics USD 39K 768K Jun/2025
Divis Laboratories Ltd 27.44B 5.42B Mar/2025
IQVIA Holdings USD 3.41B 95M Jun/2025
Kangmei Pharma CNY 3.44B 269.75M Jun/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Laboratorios Farma EUR 134.29M 480K Jun/2025
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.81M 743K Dec/2024
Moderna USD 457M 151M Jun/2025
Neuren Pharmaceuticals AUD 175.72M 160.85M Dec/2024
Organigram Holdings CAD 57.55M 10.46M Jun/2025
Organon & Co USD 1.48B 27M Jun/2025
Pharma Mar EUR 67.87M 24.58M Jun/2025
Qiagen NV USD 385.76M 45.05M Jun/2025
Revvity USD 661.14M 43.72M Jun/2025
Sartorius EUR 393.2M 14.3M Jun/2025
Sino Biopharmaceutical CNY 5.26B 2.1B Dec/2024
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 112.74M 8.7M Nov/2024
Viatris USD 3.6B 208.8M Jun/2025
Xeris Pharmaceuticals USD 53.05M 12.64M Jun/2025
Zz Pientze Pharmaceu 1.34B 268.02M Jun/2025